Follow
Surendra Uranw
Title
Cited by
Cited by
Year
Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance
S Rijal, B Ostyn, S Uranw, K Rai, NR Bhattarai, TPC Dorlo, JH Beijnen, ...
Clinical Infectious Diseases 56 (11), 1530-1538, 2013
3532013
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
H Imamura, T Downing, F Van den Broeck, MJ Sanders, S Rijal, S Sundar, ...
Elife 5, e12613, 2016
1612016
Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure
TPC Dorlo, S Rijal, B Ostyn, PJ de Vries, R Singh, N Bhattarai, S Uranw, ...
The Journal of infectious diseases 210 (1), 146-153, 2014
1542014
Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial
A Picado, SP Singh, S Rijal, S Sundar, B Ostyn, F Chappuis, S Uranw, ...
Bmj 341, 2010
1232010
Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain
K Rai, B Cuypers, NR Bhattarai, S Uranw, M Berg, B Ostyn, JC Dujardin, ...
MBio 4 (5), 10.1128/mbio. 00611-13, 2013
822013
Epidemiology of Leishmania donovani infection in high‐transmission foci in Nepal
S Rijal, S Uranw, F Chappuis, A Picado, B Khanal, IS Paudel, ...
Tropical Medicine & International Health 15, 21-28, 2010
662010
Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial
K Gidwani, A Picado, S Rijal, SP Singh, L Roy, V Volfova, EW Andersen, ...
PLoS Neglected Tropical Diseases 5 (9), e1296, 2011
652011
Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal
A Picado, B Ostyn, SP Singh, S Uranw, E Hasker, S Rijal, S Sundar, ...
PloS one 9 (1), e87641, 2014
642014
PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala‐Azar
NR Bhattarai, G Van der Auwera, B Khanal, S De Doncker, S Rijal, ...
Tropical Medicine & International Health 14 (4), 404-411, 2009
632009
Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000–2010)
S Uranw, B Ostyn, A Rijal, S Devkota, B Khanal, J Menten, M Boelaert, ...
PLoS neglected tropical diseases 5 (12), e1433, 2011
622011
Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur Districts
B Ostyn, S Uranw, NR Bhattarai, ML Das, K Rai, K Tersago, Y Pokhrel, ...
PLOS Neglected Tropical Diseases 9 (8), e0003966, 2015
522015
An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani
S Uranw, E Hasker, L Roy, F Meheus, ML Das, NR Bhattarai, S Rijal, ...
BMC infectious diseases 13, 1-9, 2013
492013
The household costs of visceral leishmaniasis care in south-eastern Nepal
S Uranw, F Meheus, R Baltussen, S Rijal, M Boelaert
PLoS Neglected Tropical Diseases 7 (2), e2062, 2013
422013
Impact of the visceral leishmaniasis elimination initiative on Leishmania donovani transmission in Nepal: a 10-year repeat survey
K Cloots, S Uranw, B Ostyn, NR Bhattarai, E Le Rutte, B Khanal, A Picado, ...
The Lancet Global Health 8 (2), e237-e243, 2020
342020
Effectiveness of systematic echocardiographic screening for rheumatic heart disease in Nepalese schoolchildren: a cluster randomized clinical trial
P Karki, S Uranw, S Bastola, R Mahato, NR Shrestha, K Sherpa, ...
JAMA cardiology 6 (4), 420-426, 2021
272021
Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions in N epal
S Uranw, B Ostyn, TPC Dorlo, E Hasker, B Dujardin, JC Dujardin, S Rijal, ...
Tropical Medicine & International Health 18 (2), 179-187, 2013
262013
Residual activity and integrity of PermaNet® 2.0 after 24 months of household use in a community randomised trial of long lasting insecticidal nets against visceral …
A Picado, SP Singh, V Vanlerberghe, S Uranw, B Ostyn, H Kaur, ML Das, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 106 (3 …, 2012
212012
ChAdOx1 nCoV-19 vaccine and its self-reported adverse events: a cross-sectional study from Western Nepal
A Gautam, N Dangol, U Bhattarai, S Paudel, B Poudel, S Gautam, ...
Journal of Global Health Reports 5, e2021069, 2021
172021
Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial
GK Rai, T Saluja, S Chaudhary, D Tamrakar, P Kanodia, BR Giri, ...
The Lancet Infectious diseases 22 (4), 529-540, 2022
152022
Retrospective Q uarterly C ohort M onitoring for patients with V isceral L eishmaniasis in the I ndian subcontinent: outcomes of a pilot project
B Ostyn, P Malaviya, E Hasker, S Uranw, RP Singh, S Rijal, S Sundar, ...
Tropical Medicine & International Health 18 (6), 725-733, 2013
72013
The system can't perform the operation now. Try again later.
Articles 1–20